Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus

Herpes simplex viruses (HSV) are significant global health problems associated with mucosal and neurologic disease. Prior experimental vaccines primarily elicited neutralizing antibodies targeting glycoprotein D (gD), but those that advanced to clinical efficacy trials have failed. Preclinical studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Burn Aschner, Clare, Pierce, Carl, Knipe, David M., Herold, Betsy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350019/
https://www.ncbi.nlm.nih.gov/pubmed/32516944
http://dx.doi.org/10.3390/vaccines8020277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350019/
https://www.ncbi.nlm.nih.gov/pubmed/32516944
http://dx.doi.org/10.3390/vaccines8020277

Ejemplares similares